61 |
Energetic, structural and dynamic evaluation of HIV-1 proteasesNaicker, Previn 06 February 2015 (has links)
A thesis submitted to the Faculty of Science, University of the Witwatersrand, Johannesburg, in fulfilment of the requirements for the degree of Doctor of Philosophy. August 2014. / Human immunodeficiency virus (HIV), the causative agent of the acquired
immunodeficiency syndrome (AIDS), remains a topic of global concern even though great
strides have been made to combat the virus. The high replicative rate of the virus and
recombination of the variety of viral strains complicate the treatment of AIDS. There has
been an increasing prevalence of African HIV strains in the Americas and Europe. The viral
protease (PR) is vital for the propagation of the virus; and thus, is a major target in antiviral
therapy. The HIV-1 PR enzyme from the subtype C strain; which predominates in sub-
Saharan Africa, has been greatly under-investigated in comparison to the protease from the
subtype B strain which predominates in North America and Europe. Enzyme activity data
which were part of this work suggested that the South African HIV-1 subtype C protease (CSA
PR) displays improved substrate turnover in comparison to the subtype B PR.
Thermodynamics and inhibition kinetics of drug binding showed that the C-SA PR is less
susceptible to certain clinically-used protease inhibitors when compared to the subtype B PR.
A crystal structure of the C-SA PR was solved and showed no difference to the global
structure of the subtype B PR. Molecular dynamics simulations showed that the C-SA PR
exhibits a wider range of open conformations. Hydrogen/deuterium exchange-mass
spectrometry (HDX-MS) was performed to elucidate the mechanism of reduced drug
susceptibility displayed by the C-SA PR. HDX-MS data provided insights into the basis of
the increased preference for open conformers displayed by the C-SA PR and the stability of
the terminal dimer interface which is a target in protease inhibition.
|
62 |
Activation of human protease-activated receptors by proteases from a periodontal pathogenLourbakos, Afrodite, 1972- January 2001 (has links)
Abstract not available
|
63 |
Proteolytic processing of HIV-1 Gag and GagProPol precursor proteins, genomic RNA rearrangement and virion cor formation are interrelatedXhilaga, Miranda, 1965- January 2001 (has links)
Abstract not available
|
64 |
Functional characterization of PAG1, the [alpha]7 subunit of the 20S proteasome and of the ubiquitin-specific protease subfamilies UBP12/13 and UBP3/4 in Arabidopsis thalianaSoyler-Ogretim, Gulsum. January 1900 (has links)
Thesis (Ph. D.)--West Virginia University, 2009. / Title from document title page. Document formatted into pages; contains ix, 89 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references (p. 82-88).
|
65 |
Toward high throughput directed evolution of protease specificity using fluorescence activated cell sortingGam, Jongsik 28 August 2008 (has links)
Not available / text
|
66 |
Design, synthesis and evaluation of novel inhibitors of cysteine proteases, metalloproteases and the proteasome, a unique high molecular weight proteolytic enzymeDotse, Anthony Kwabla 08 1900 (has links)
No description available.
|
67 |
Development of a structural model of human T-cell leukemia virus type-I proteaseDennison, Kelly J. 08 1900 (has links)
No description available.
|
68 |
Endolysosomal proteolysis and its regulation.Pillay, Ché Sobashkar. January 2003 (has links)
The endolysosomal system is a multifunctional system and is involved in catabolism,
antigen presentation and regulation of hormones. The descriptions of, and functions
assigned to organelles within the system are often applied using different criteria. Further,
the properties of the hydrolases within the system, and the organelles that house them are
usually studied in isolation from one another. Considering that the endolysosomal system
may be extremely dynamic, an understanding of the system as an integrated whole is a
necessary first step. Thus, a review of the endolysosomal system was undertaken. It was
determined that the enzymes within the endolysosomal system are probably subject to
'organelle-dependent' regulation, i.e. the organelles create the appropriate luminal conditions
for these enzymes to work. It is also likely that the effectors of these luminal conditions
are regulated in a manner that is related to GTPase networks that control much of the cell's
functions. The organisation of the endolysosomal system may be hierarchical, with
proteases being downstream effectors of a system that is regulated at the whole body level.
The main endoprotease class within the endolysosomal system are cysteine proteases. A
literature review suggested that these enzymes may not be redox regulated within the
endolysosomal system. However, the lysosomal endoprotease cathepsin B has been
implicated in many pathologies where it is operating in pH and redox conditions different
from the endolysosomal system. To study this, cathepsin B was isolated from bovine
livers using a novel procedure that exploits the ability of tertiary butanol to temporarily
inhibit protease interactions in tissue homogenates. This would prevent artefactual, as well
as protease-inhibitor interactions. This novel procedure resulted in increased yields of
cathepsin B. Cathepsin D, an aspartic protease, was isolated using established methods.
In order to test the hypothesis that cathepsin B may be redox regulated in vivo, cathepsin B
activity and stability were measured in cysteine and/or cystine-containing redox buffers.
Cathepsin B activity in cysteine-containing buffers was similar at pH 6.0 and pH 7.0, over
all thiol concentrations tested. In contrast, the stability of the enzyme was greater at pH
6.0 than at pH 7.0. This suggests that the enzyme's operational pH in vivo may be < pH
7.0. The activity of the enzyme was depressed in glutathione-containing buffers. When
assessed in cysteine:cystine redox buffers (pH 6.0 - 7.0) cathepsin B was active over a
broad redox potential range, suggesting that cathepsin B activity may not be redox regulated. / Thesis (Ph.D.)-University of Natal, Pietermaritzburg, 2003.
|
69 |
Affinity precipitation of proteasesCampbell, Alyson Ann January 1996 (has links)
No description available.
|
70 |
B. amyloliquefaciens alkaline protease synthesis : gene cloning /Bawden, Michael James. January 1984 (has links) (PDF)
Thesis (Ph. D.)--University of Adelaide, Dept. of Biochemistry, 1984. / Includes bibliographical references (leaves 118-130).
|
Page generated in 0.0575 seconds